Diagnostic criteria and diagnostic algorithm for IPF

/

Diagnostic criteria and diagnostic algorithm for IPF

An early and accurate diagnosis of IPF is critical

Early diagnosis of IPF allows for appropriate management of symptoms and quality-of-life issues in patients with this disease1-3 

 

 

1. Wells AU. Eur Respir Rev. 2013;22:158-162. 2. du Bois RM. Eur Respir Rev. 2012;21(124):141-146. 3. Lamas DJ et al. Am J Respir Crit Care Med. 2011;184(7):842-847. 4. Collard HR et al. Am J Respir Crit Care Med2003;168:538-542.

Early diagnosis is essential for timely referral to a lung transplant center for patients with advanced disease4

2

Diagnostic criteria for IPF

 

Current diagnostic criteria

According to the 2018 ATS/ERS/JRS/ALAT guideline criteria, diagnosing IPF requires the following5:

 

5. Raghu G et al. Am J Respir Crit Care Med. 2018;198(5):e44-e68.

1

Exclusion of other known causes of ILD and either #2 or #3

2

A UIP pattern on HRCT

3

Specific combinations of HRCT and histopathology patterns (in patients who undergo an SLB)

ILD, interstitial lung disease; HRCT, high-resolution computed tomography; SLB, surgical lung biopsy.

4

Diagnostic algorithm

Suspected ILD

  • Physical exam
  • History
  • PFT results
  • 5. Raghu G et al. Am J Respir Crit Care Med. 2018;198(5):e44-e68. 6. Raghu G et al. Am J Respir Crit Care Med. 2011;183(6):788-824. 7. Ley B et al. Am J Respir Crit Care Med. 2011;183(4):431-440.

    When you suspect a patient has an ILD, the first things to do are5-7:

    -Perform a physical exam
    -Take a complete history, including exposures
    -Evaluate pulmonary function through PFTs

    PFT, pulmonary function test

    5

    Diagnostic algorithm

    Signs of IPF on physical exam:5

  • Typically affects adults >60 years of age
  • Chronic exertional dyspnea
  • Dry, nonproductive cough
  • Crackles or rales on auscultation
  • May show signs of digital clubbing
  • Reprinted with permission of the American Thoracic Society. Copyright © 2018 American Thoracic Society. Raghu G, Remy-Jardin M, et al. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018;198(5):e44-e68.Official Journal of the American Thoracic Society.

    5. Raghu G et al. Am J Respir Crit Care Med. 2018;198(5):e44-e68.

     

    Suspected ILD

  • Physical exam
  • History
  • PFT results
  • 6

    Diagnostic algorithm

    Signs of IPF based on history:5

  • Current or former smoker
  • Exposure to any number of dusts (eg, stone, silica, wood)
  • Agriculture and/or bird exposures
  • Viral exposures (eg, Hepatitis C)
  • Family history of pulmonary fibrosis
  • 5. Raghu G et al. Am J Respir Crit Care Med. 2018;198(5):e44-e68.

    Suspected ILD

  • Physical exam
  • History
  • PFT results
  • 7

    Reprinted with permission of the American Thoracic Society. Copyright © 2018 American Thoracic Society. Raghu G, Remy-Jardin M, et al. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018;198(5):e44-e68.Official Journal of the American Thoracic Society.

    Diagnostic algorithm

    Signs of IPF on PFTs:8,9

  • Restrictive physiology
  • Reduced TLC
  • Increased FEV1/FVC ratio
  • Reduced DLco
  • Reduced predicted FVC
  • Desaturation on exertion
  •  

     

    8. Pellegrino R et al. Eur Respir J. 2005;26(5):948-968. 9. Meltzer EB et al. Orphanet J Rare Dis. 2008;3:1-15.

    Suspected ILD

  • Physical exam
  • History
  • PFT results
  • 8

    Reprinted with permission of the American Thoracic Society. Copyright © 2018 American Thoracic Society. Raghu G, Remy-Jardin M, et al. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018;198(5):e44-e68.Official Journal of the American Thoracic Society.

    Probable UIP, Indeterminate for UIP, or Alternative diagnosis

    Diagnostic algorithm

    5. Raghu G et al. Am J Respir Crit Care Med. 2018;198(5):e44-e68.

    9

    Identifiable cause/ associated condition?

    CTD on serologic testing?

    HRCT results

    IPF

    YES

    YES

    Not UIP

    UIP

    Biopsy

    Not

    IPF

    NO

    NO

     

    Suspected ILD

  • Physical exam
  • History
  • PFT results
  • Further evaluation

    YES

    NO

    Specific Diagnosis

     

     

    MDD

    BAL

    MDD

    Alternative Diagnosis

     

     

     

     

    Reprinted with permission of the American Thoracic Society. Copyright © 2018 American Thoracic Society. Raghu G, Remy-Jardin M, et al. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018;198(5):e44-e68.Official Journal of the American Thoracic Society.

    Diagnostic algorithm

    5. Raghu G et al. Am J Respir Crit Care Med. 2018;198(5):e44-e68. 10. European Respiratory Society. White Book: ILDs. http://www.erswhitebook.org/chapters/interstitial-lung-diseases/

    10

    Identifiable cause/ associated condition?

    CTD on serologic testing?

    HRCT results

    IPF

    YES

    YES

    Not UIP

    UIP

    Probable UIP, Indeterminate for UIP, or Alternative diagnosis

    Biopsy

    Not

    IPF

    NO

    NO

     

    Suspected ILD

  • Physical exam
  • History
  • PFT results
  • Further evaluation

    YES

    NO

    Specific Diagnosis

     

     

    MDD

    BAL

    MDD

    Alternative Diagnosis

     

     

    Many ILDs have identifiable causes:10

  • Hypersensitivity pneumonitis
  • Asbestosis
  • Silicosis
  • Post-infectious ILD
  • Drug-induced ILD
  •  

     

     

    Reprinted with permission of the American Thoracic Society. Copyright © 2018 American Thoracic Society. Raghu G, Remy-Jardin M, et al. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018;198(5):e44-e68.Official Journal of the American Thoracic Society.

    Probable UIP, Indeterminate for UIP, or Alternative diagnosis

    Identifiable cause/ associated condition?

    CTD on serologic testing?

    HRCT results

    IPF

    YES

    YES

    Not UIP

    UIP

    Biopsy

    Not

    IPF

    NO

    NO

     

    Suspected ILD

  • Physical exam
  • History
  • PFT results
  • Further evaluation

    YES

    NO

    Specific Diagnosis

     

     

    MDD

    BAL

    MDD

    Alternative Diagnosis

     

    Diagnostic algorithm

     

    5. Raghu G et al. Am J Respir Crit Care Med. 2018;198(5):e44-e68.

    11

     

    If there are no obvious causes of ILD based on patient history, you should continue to suspect IPF.

    Reprinted with permission of the American Thoracic Society. Copyright © 2018 American Thoracic Society. Raghu G, Remy-Jardin M, et al. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018;198(5):e44-e68.Official Journal of the American Thoracic Society.

    Probable UIP, Indeterminate for UIP, or Alternative diagnosis

    Identifiable cause/ associated condition?

    CTD on serologic testing?

    HRCT results

    IPF

    YES

    YES

    Not UIP

    UIP

    Biopsy

    Not

    IPF

    NO

    NO

     

    Suspected ILD

  • Physical exam
  • History
  • PFT results
  • Further evaluation

    YES

    NO

    Specific Diagnosis

     

     

    MDD

    BAL

    MDD

    Alternative Diagnosis

     

    Diagnostic algorithm

    5. Raghu G et al. Am J Respir Crit Care Med. 2018;198(5):e44-e68. 6. Raghu G et al. Am J Respir Crit Care Med. 2011;183(6):788-824.

    12

     

     

    The next step is to consider performing serologic testing to evaluate for CTD5,6

  • Screens include: RF, anti-CCP, ANA
  •  

    These tests should be paired with clinical signs of CTD (eg, arthralgia/synovitis, proximal muscle weakness, Raynaud’s phenomenon).

    CTD, connective tissue disorder; HP, hypersensitivity pneumonitis; RF, rheumatoid factor; CCP, cyclic citrullinated peptide; ANA, anti-nuclear antibody.

    Probable UIP, Indeterminate for UIP, or Alternative diagnosis

    Identifiable cause/ associated condition?

    CTD on serologic testing?

    HRCT results

    IPF

    YES

    YES

    Not UIP

    UIP

    Biopsy

    Not

    IPF

    NO

    NO

     

    Suspected ILD

  • Physical exam
  • History
  • PFT results
  • Further evaluation

    YES

    NO

    Specific Diagnosis

     

     

    MDD

    BAL

    MDD

    Alternative Diagnosis

     

    Diagnostic algorithm

    5. Raghu G et al. Am J Respir Crit Care Med. 2018;198(5):e44-e68.

    13

     

     

    Reprinted with permission of the American Thoracic Society. Copyright © 2018 American Thoracic Society. Raghu G, Remy-Jardin M, et al. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018;198(5):e44-e68.Official Journal of the American Thoracic Society.

    Probable UIP, Indeterminate for UIP, or Alternative diagnosis

    Identifiable cause/ associated condition?

    CTD on serologic testing?

    HRCT results

    IPF

    YES

    YES

    Not UIP

    UIP

    Biopsy

    Not

    IPF

    NO

    NO

     

    Suspected ILD

  • Physical exam
  • History
  • PFT results
  • Further evaluation

    YES

    NO

    Specific Diagnosis

     

     

    MDD

    BAL

    MDD

    Alternative Diagnosis

     

    Diagnostic algorithm

    5. Raghu G et al. Am J Respir Crit Care Med. 2018;198(5):e44-e68.

    14

     

    If there are no elevations in CTD markers, you should continue to suspect IPF.

    Reprinted with permission of the American Thoracic Society. Copyright © 2018 American Thoracic Society. Raghu G, Remy-Jardin M, et al. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018;198(5):e44-e68.Official Journal of the American Thoracic Society.

    Probable UIP, Indeterminate for UIP, or Alternative diagnosis

    Identifiable cause/ associated condition?

    CTD on serologic testing?

    HRCT results

    IPF

    YES

    YES

    Not UIP

    UIP

    Biopsy

    Not

    IPF

    NO

    NO

     

    Suspected ILD

  • Physical exam
  • History
  • PFT results
  • Further evaluation

    YES

    NO

    Specific Diagnosis

     

     

    MDD

    BAL

    MDD

    Alternative Diagnosis

     

    Diagnostic algorithm

    5. Raghu G et al. Am J Respir Crit Care Med. 2018;198(5):e44-e68. 11. Mathieson JR et al. Radiol. 1989;171(1):111-116. 12. Hunninghake GW et al. Am J Respir Crit Care Med. 2001;164(2):193-196.  13. Raghu G et al. Chest. 1999;116(5):1168-1174. 14. Grenier P et al. Radiology. 1991;179(1):123-132. 15. Lee KS et al. Radiology. 1994;191(3):669-673. 16. Swensen SJ et al. Radiology. 1997;205(1):229-234.

     

    Next, patients should have an HRCT performed5

  • The positive predictive value of a definite UIP pattern on HRCT is 90%-100%11-16
  • UIP pattern on HRCT should be paired with an exclusion of other causes of ILD before reaching a diagnosis of IPF5
  • 15

    Reprinted with permission of the American Thoracic Society. Copyright © 2018 American Thoracic Society. Raghu G, Remy-Jardin M, et al. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018;198(5):e44-e68.Official Journal of the American Thoracic Society.

    Diagnostic algorithm

    5. Raghu G et al. Am J Respir Crit Care Med. 2018;198(5):e44-e68.

    16

    Identifiable cause/ associated condition?

    CTD on serologic testing?

    HRCT results

    IPF

    YES

    YES

    Not UIP

    UIP

    Biopsy

    Not

    IPF

    NO

    NO

     

    Suspected ILD

  • Physical exam
  • History
  • PFT results
  • Further evaluation

    YES

    NO

    Specific Diagnosis

     

     

    MDD

    BAL

    MDD

    Alternative Diagnosis

     

     

    Reprinted with permission of the American Thoracic Society. Copyright © 2018 American Thoracic Society. Raghu G, Remy-Jardin M, et al. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018;198(5):e44-e68.Official Journal of the American Thoracic Society.

    Probable UIP, Indeterminate for UIP, or Alternative diagnosis

    Probable UIP, Indeterminate for UIP, or Alternative diagnosis

    Diagnostic algorithm

     

    5. Raghu G et al. Am J Respir Crit Care Med. 2018;198(5):e44-e68. 17. Lynch DA et al. Lancet. 2018;6(2):138-153.

    17

    Identifiable cause/ associated condition?

    CTD on serologic testing?

    HRCT results

    IPF

    YES

    YES

    Not UIP

    UIP

    Biopsy

    Not

    IPF

    NO

    NO

     

    Suspected ILD

  • Physical exam
  • History
  • PFT results
  • Further evaluation

    YES

    NO

    Specific Diagnosis

     

     

    MDD

    BAL

    MDD

    Alternative Diagnosis

     

     

    HRCT: UIP pattern5,17

    UIP

    Image courtesy of and used with permission from Sudhakar Pipavath, MD.

    1.Subpleural, basal predominance
    2.Honeycombing
    3.Bronchiectasis/bronchiolectasis
    4.Absence/paucity of:
  • Micronodules
  • Discrete cysts
  • Consolidation
  • Mosaic attenuation/air trapping
  • Ground glass opacity
  • Reprinted with permission of the American Thoracic Society. Copyright © 2018 American Thoracic Society. Raghu G, Remy-Jardin M, et al. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018;198(5):e44-e68.Official Journal of the American Thoracic Society.

    Probable UIP, Indeterminate for UIP, or Alternative diagnosis

    Diagnostic algorithm

    5. Raghu G et al. Am J Respir Crit Care Med. 2018;198(5):e44-e68. 17. Lynch DA et al. Lancet. 2018;6(2):138-153.

    18

    Identifiable cause/ associated condition?

    CTD on serologic testing?

    HRCT results

    IPF

    YES

    YES

    Not UIP

    UIP

    Biopsy

    Not

    IPF

    NO

    NO

     

    Suspected ILD

  • Physical exam
  • History
  • PFT results
  • Further evaluation

    YES

    NO

    Specific Diagnosis

     

     

    MDD

    BAL

    MDD

    Alternative Diagnosis

     

     

    A UIP pattern on HRCT, paired with a lack of identifiable cause, is sufficient to diagnose IPF.5,17

     

    Reprinted with permission of the American Thoracic Society. Copyright © 2018 American Thoracic Society. Raghu G, Remy-Jardin M, et al. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018;198(5):e44-e68.Official Journal of the American Thoracic Society.

    Probable UIP, Indeterminate for UIP, or Alternative diagnosis

    Identifiable cause/ associated condition?

    CTD on serologic testing?

    HRCT results

    IPF

    YES

    YES

    Not UIP

    UIP

    Biopsy

    Not

    IPF

    NO

    NO

     

    Suspected ILD

  • Physical exam
  • History
  • PFT results
  • Further evaluation

    YES

    NO

    Specific Diagnosis

     

     

    MDD

    BAL

    MDD

    Alternative Diagnosis

     

    Diagnostic algorithm

    5. Raghu G et al. Am J Respir Crit Care Med. 2018;198(5):e44-e68. 6. Raghu G et al. Am J Respir Crit Care Med. 2011;183(6):788-824. 17. Lynch DA et al. Lancet. 2018;6(2):138-153.

    19

     

    HRCT: Probable UIP pattern5,17

    Probable UIP

    Image courtesy of and used with permission from Sudhakar Pipavath, MD.

    1.Subpleural, basal predominance
    2.Reticulation with mild bronchiectasis/bronchiolectasis
    3.Absence/paucity of:
  • Micronodules
  • Discrete cysts
  • Consolidation
  • Mosaic attenuation/air trapping
  • Ground glass opacity
  • Reprinted with permission of the American Thoracic Society. Copyright © 2018 American Thoracic Society. Raghu G, Remy-Jardin M, et al. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018;198(5):e44-e68.Official Journal of the American Thoracic Society.

    Image used with permission from the American Thoracic Society. © 2014. Raghu G et al.6

    Probable UIP, Indeterminate for UIP, or Alternative diagnosis

    Identifiable cause/ associated condition?

    CTD on serologic testing?

    HRCT results

    IPF

    YES

    YES

    Not UIP

    UIP

    Biopsy

    Not

    IPF

    NO

    NO

     

    Suspected ILD

  • Physical exam
  • History
  • PFT results
  • Further evaluation

    YES

    NO

    Specific Diagnosis

     

     

    MDD

    BAL

    MDD

    Alternative Diagnosis

     

    Diagnostic algorithm

    5. Raghu G et al. Am J Respir Crit Care Med. 2018;198(5):e44-e68. 17. Lynch DA et al. Lancet. 2018;6(2):138-153.

    20

     

     

    HRCT: Indeterminate pattern5,17

    Indeterminate

    1.Subpleural, basal predominance
    2.Subtle reticulation, indeterminate   CT features
    3.Absence/paucity of:
  • Micronodules
  • Discrete cysts
  • Consolidation
  • Mosaic attenuation/air trapping
  • Ground glass opacity
  • Reprinted with permission of the American Thoracic Society. Copyright © 2018 American Thoracic Society. Raghu G, Remy-Jardin M, et al. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018;198(5):e44-e68.Official Journal of the American Thoracic Society.

    Image courtesy of and used with permission from Robert Suh, MD.

    Probable UIP, Indeterminate for UIP, or Alternative diagnosis

    Identifiable cause/ associated condition?

    CTD on serologic testing?

    HRCT results

    IPF

    YES

    YES

    Not UIP

    UIP

    Biopsy

    Not

    IPF

    NO

    NO

     

    Suspected ILD

  • Physical exam
  • History
  • PFT results
  • Further evaluation

    YES

    NO

    Specific Diagnosis

     

     

    MDD

    BAL

    MDD

    Alternative Diagnosis

     

    Diagnostic algorithm

    5. Raghu G et al. Am J Respir Crit Care Med. 2018;198(5):e44-e68. 17. Lynch DA et al. Lancet. 2018;6(2):138-153.

    21

     

    HRCT: Alternative Diagnosis5,17

    Alternative Diagnosis

    Image courtesy of and used with permission from Sudhakar Pipavath, MD.

    1.Upper/mid-lung predominance
    2.Peribronchovascular predominance
    3.Extensive ground glass abnormality (extent > reticular abnormality)
    4.Substantial extent of any of the following:
  • Consolidation
  • Micronodules
  • Discrete cysts
  • Mosaic attenuation/air trapping
  •  

    Image courtesy of and used with permission from Jonathan Goldin, MD, PhD.

    Reprinted with permission of the American Thoracic Society. Copyright © 2018 American Thoracic Society. Raghu G, Remy-Jardin M, et al. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018;198(5):e44-e68.Official Journal of the American Thoracic Society.

    Probable UIP, Indeterminate for UIP, or Alternative diagnosis

    Identifiable cause/ associated condition?

    CTD on serologic testing?

    HRCT results

    IPF

    YES

    YES

    Not UIP

    UIP

    Biopsy

    Not

    IPF

    NO

    NO

     

    Suspected ILD

  • Physical exam
  • History
  • PFT results
  • Further evaluation

    YES

    NO

    Specific Diagnosis

     

     

    MDD

    BAL

    MDD

    Alternative Diagnosis

     

    Diagnostic algorithm

    5. Raghu G et al. Am J Respir Crit Care Med. 2018;198(5):e44-e68. 17. Lynch DA et al. Lancet. 2018;6(2):138-153.

    Cases of probable UIP pattern, indeterminate, or potential alternative diagnosis should undergo biopsy (when possible) and MDD to ensure a more accurate diagnosis.5,17

    MDD, multidisciplinary discussion

    22

     

     

    Reprinted with permission of the American Thoracic Society. Copyright © 2018 American Thoracic Society. Raghu G, Remy-Jardin M, et al. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018;198(5):e44-e68.Official Journal of the American Thoracic Society.

    Probable UIP, Indeterminate for UIP, or Alternative diagnosis

    Identifiable cause/ associated condition?

    CTD on serologic testing?

    HRCT results

    IPF

    YES

    YES

    Not UIP

    UIP

    Biopsy

    Not

    IPF

    NO

    NO

     

    Suspected ILD

  • Physical exam
  • History
  • PFT results
  • Further evaluation

    YES

    NO

    Specific Diagnosis

     

     

    MDD

    BAL

    MDD

    Alternative Diagnosis

     

    Diagnostic algorithm

    5. Raghu G et al. Am J Respir Crit Care Med. 2018;198(5):e44-e68. 17. Lynch DA et al. Lancet. 2018;6(2):138-153.

    23

     

     

    Histopathology: UIP pattern5,17

    Image used with permission from the American Thoracic Society. © 2018. Raghu G et al.5

    1.Dense fibrosis with architectural distortion (ie, destructive scarring and/or honeycombing)
    2.Predominant subpleural and/or paraseptal distribution of fibrosis
    3.Patchy involvement of lung parenchyma by fibrosis
    4.Fibroblast foci
    5.Absence of features to suggest an alternate diagnosis

    UIP

    Probable UIP, Indeterminate for UIP, or Alternative diagnosis

    Identifiable cause/ associated condition?

    CTD on serologic testing?

    HRCT results

    IPF

    YES

    YES

    Not UIP

    UIP

    Biopsy

    Not

    IPF

    NO

    NO

     

    Suspected ILD

  • Physical exam
  • History
  • PFT results
  • Further evaluation

    YES

    NO

    Specific Diagnosis

     

     

    MDD

    BAL

    MDD

    Alternative Diagnosis

     

    Diagnostic algorithm

    5. Raghu G et al. Am J Respir Crit Care Med. 2018;198(5):e44-e68. 17. Lynch DA et al. Lancet. 2018;6(2):138-153.

    24

     

     

    Histopathology: Probable UIP pattern5,17

    Image used with permission from the American Thoracic Society. © 2018. Raghu G et al.5

    1.Some histologic features from UIP are present but to an extent that precludes definite diagnosis of UIP/IPF

    AND

    2.Absence of features to suggest an alternative diagnosis (see alternative diagnosis section)

    OR

    3.Honeycombing only

    Probable UIP

    Probable UIP, Indeterminate for UIP, or Alternative diagnosis

    Identifiable cause/ associated condition?

    CTD on serologic testing?

    HRCT results

    IPF

    YES

    YES

    Not UIP

    UIP

    Biopsy

    Not

    IPF

    NO

    NO

     

    Suspected ILD

  • Physical exam
  • History
  • PFT results
  • Further evaluation

    YES

    NO

    Specific Diagnosis

     

     

    MDD

    BAL

    MDD

    Alternative Diagnosis

     

    Diagnostic algorithm

    5. Raghu G et al. Am J Respir Crit Care Med. 2018;198(5):e44-e68. 17. Lynch DA et al. Lancet. 2018;6(2):138-153.

    25

     

     

    Histopathology: Indeterminate for pattern5,17

    Image used with permission from the American Thoracic Society. © 2018. Raghu G et al.5

    1.Fibrosis with or without architectural distortion, with features favoring either a pattern other than UIP or features favoring UIP secondary to another cause
    2.Some histologic features of UIP, but with other features suggesting an alternative diagnosis

    Indeterminate for UIP

    Probable UIP, Indeterminate for UIP, or Alternative diagnosis

    Reprinted with permission of the American Thoracic Society. Copyright © 2018 American Thoracic Society. Raghu G, Remy-Jardin M, et al. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018;198(5):e44-e68.Official Journal of the American Thoracic Society.

    Diagnostic algorithm

    5. Raghu G et al. Am J Respir Crit Care Med. 2018;198(5):e44-e68. 17. Lynch DA et al. Lancet. 2018;6(2):138-153.

    26

    Identifiable cause/ associated condition?

    CTD on serologic testing?

    HRCT results

    IPF

    YES

    YES

    Not UIP

    UIP

    Biopsy

    Not

    IPF

    NO

    NO

     

    Suspected ILD

  • Physical exam
  • History
  • PFT results
  • Further evaluation

    YES

    NO

    Specific Diagnosis

     

     

    MDD

    BAL

    MDD

    Alternative Diagnosis

     

     

     

    Histopathology: Alternative diagnosis5,17

    Image courtesy of and used with permission from Kirk Jones, MD.

    1.Features of other histologic patterns of IIPs (eg, absence of fibroblast foci or loose fibrosis) in all biopsies
    2.Histologic findings indicative of other diseases (eg, hypersensitivity pneumonitis, Langerhans cell histiocytosis, sarcoidosis, LAM)

    Alternative diagnosis

    Probable UIP, Indeterminate for UIP, or Alternative diagnosis

    Diagnostic algorithm

    5. Raghu G et al. Am J Respir Crit Care Med. 2018;198(5):e44-e68. 17. Lynch DA et al. Lancet. 2018;6(2):138-153.

    MDD, multidisciplinary discussion

    27

    Identifiable cause/ associated condition?

    CTD on serologic testing?

    HRCT results

    IPF

    YES

    YES

    Not UIP

    UIP

    Biopsy

    Not

    IPF

    NO

    NO

     

    Suspected ILD

  • Physical exam
  • History
  • PFT results
  • Further evaluation

    YES

    NO

    Specific Diagnosis

     

     

    MDD

    BAL

    MDD

    Alternative Diagnosis

     

    An MDD provides a sounding board to evaluate all evidence to come up with a consensus diagnosis, whether that is IPF or another ILD.5,17

    Reprinted with permission of the American Thoracic Society. Copyright © 2018 American Thoracic Society. Raghu G, Remy-Jardin M, et al. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018;198(5):e44-e68.Official Journal of the American Thoracic Society.

    Diagnostic algorithm – designating the HRCT and histopathology pattern

    28

    Suspected Case of IPF

     

    Histopathology

     

     

     

     

     

    UIP

    Probable UIP

    Indeterminate UIP

    Alternative Diagnosis

    HRCT results

    UIP

    IPF

    IPF

    IPF

    Not IPF

     

    Probable UIP

    IPF

    IPF

    IPF Likely

    Not IPF

     

    Indeterminate UIP

    IPF

    IPF Likely

    Indeterminate

    Not IPF

     

    Alternative Diagnosis

    IPF (likely) or non-IPF

    Not IPF

    Not IPF

    Not IPF

    Adapted from Raghu G et al. Am J Respir Crit Care Med. 2018;198(5):e44-e68.

    5. Raghu G et al. Am J Respir Crit Care Med. 2018;198(5):e44-e68.

    Likely IPF:

  • Moderate to severe bronchiectasis in four or more lobes, or moderate to severe bronchiectasis  in two or more lobes in a man over 50 or woman over 60
  • Extensive reticulation on HRCT for individuals over >70
  • Increased neutrophils and/or absence of lymphocytes upon BAL
  • MDD reaches confident diagnosis 
  • Indeterminate:

  • Unlikely without adequate biopsy
  • Can be reclassified based on adequate biopsy or MDD conclusion
  • Probable UIP, Indeterminate for UIP, or Alternative diagnosis

    Diagnostic algorithm

    5. Raghu G et al. Am J Respir Crit Care Med. 2018;198(5):e44-e68.

    29

    Identifiable cause/ associated condition?

    CTD on serologic testing?

    HRCT results

    IPF

    YES

    YES

    Not UIP

    UIP

    Biopsy

    Not

    IPF

    NO

    NO

     

    Suspected ILD

  • Physical exam
  • History
  • PFT results
  • Further evaluation

    YES

    NO

    Specific Diagnosis

     

     

    MDD

    BAL

    MDD

    Alternative Diagnosis

     

    Reprinted with permission of the American Thoracic Society. Copyright © 2018 American Thoracic Society. Raghu G, Remy-Jardin M, et al. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018;198(5):e44-e68.Official Journal of the American Thoracic Society.

    References

    1.Wells AU. Eur Respir Rev. 2013;22(128):158-162.
    2.du Bois RM. Eur Respir Rev. 2012;21(124):141-146.
    3.Lamas DJ et al. Am J Respir Crit Care Med. 2011;184(7):842-847.
    4.Collard HR et al. Am J Respir Crit Care Med2003;168(5):538-542.
    5.Raghu G et al. Am J Respir Crit Care Med. 2018;198(5):e44-e68.
    6.Raghu G et al. Am J Respir Crit Care Med. 2011;183(6):788-824.
    7.Ley B et al. Am J Respir Crit Care Med. 2011;183(4):431-440.
    8.Pellegrino R et al. Eur Respir J. 2005;26(5):948-968.
    9.Meltzer EB et al. Orphanet J Rare Dis. 2008;3:1-15.
    10.European Respiratory Society. White Book: ILDs. http://www.erswhitebook.org/chapters/interstitial-lung-diseases/
    11.Mathieson JR et al. Radiol. 1989;171(1):111-116.
    12.Hunninghake GW et al. Am J Respir Crit Care Med. 2001;164(2):193-196.
    13.Raghu G et al. Chest. 1999;116(5):1168-1174.
    14.Grenier P et al. Radiology. 1991;179(1):123-132.
    15.Lee KS et al. Radiology. 1994;191(3):669-673.
    16.Swensen SJ et al. Radiology. 1997;205(1):229-234.
    17.Lynch DA et al. Lancet. 2018;6(2):138-153.

     

    30